The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 2.9M data for 1.2M Compounds and 9.3K Targets. Of those, 1,352K data for 627K Compounds and 4.5K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

14 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Bromo-deaza-SAH: a potent and selective DOT1L inhibitor.EBI
Entremed
Potent Uncompetitive Inhibitors of Nicotinamide EBI
Harvard University
Peptide-to-Small Molecule: A Pharmacophore-Guided Small Molecule Lead Generation Strategy from High-Affinity Macrocyclic Peptides.EBI
Shionogi
Potent Inhibition of Nicotinamide EBI
Leiden University
Macrocyclic Peptides as a Novel Class of NNMT Inhibitors: A SAR Study Aimed at Inhibitory Activity in the Cell.EBI
Shionogi
Novel Pyrimidine-5-carboxamide Compounds as NNMT Inhibitors for Treating Diabetes.EBI
Smith, Gambrell & Russell
High-Affinity Alkynyl Bisubstrate Inhibitors of Nicotinamide EBI
Biokin
Discovery of Bisubstrate Inhibitors for Protein N-Terminal Methyltransferase 1.EBI
Purdue University
Novel Propargyl-Linked Bisubstrate Analogues as Tight-Binding Inhibitors for Nicotinamide EBI
TBA
Bisubstrate Inhibitors of Nicotinamide EBI
Leiden University
Covalent inhibitors of nicotinamide N-methyltransferase (NNMT) provide evidence for target engagement challenges in situ.EBI
The Scripps Research Institute
Novel nicotinamide analog as inhibitor of nicotinamide N-methyltransferase.EBI
Sanofi-Aventis Deutschland
Discovery of Bisubstrate Inhibitors of Nicotinamide N-Methyltransferase (NNMT).EBI
Icahn School of Medicine At Mount Sinai